Scholarlink

Objective <p>Sarcoidosis is an inflammatory granulomatous disease of unknown cause, and cardiac sarcoidosis (CS) is the main cause of death in patients with sarcoidosis. Cardiac <sup>18</sup>F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is used to detect active CS, based on the patterns of <sup>18</sup>F-FDG uptake in the myocardium. In this study, we investigated the ability of a model observer, Channelized Hoteling Observer (CHO), in differentiating the active CS pattern, in comparison with the diagnosis by the expert cardiac nuclear medicine (NM) physician as a reference standard.</p> Methods <p>This retrospective study included 223 patients who underwent <sup>18</sup>F-FDG PET scans because they were clinically suspected of having CS. One expert cardiac NM physician and one oncology NM physician classified the cardiac <sup>18</sup>F-FDG uptake into four patterns (focal, focal on diffuse, diffuse, none) for all PET images. The oncology NM physician additionally determined the confidence scale of CS expressed as a percentage (0-100). The focal and focal on diffuse patterns were defined as CS patterns. In CHO, 80 subjects (CS: 40, non-CS: 40) were used for training data sets, and 143 subjects (CS: 66, non-CS: 77) were used for evaluation data sets of objective CS discrimination ability, respectively. The confidence scale of CS by CHO was also output as a percentage (0-100). Finally, ROC analysis was used to compare discrimination ability between the oncology NM physician and CHO by refereeing the classification of the cardiac NM physician as a standard.</p> Results <p>The match rate of classified subject numbers between the two physicians was moderate (Kappa coefficient of 0.57). In comparison with the judgment of the expert cardiac NM physician, the area under the ROC curve of oncology NM medicine and that of CHO were 0.73 and 0.78, respectively.</p> Conclusions <p>The detection ability of CHO in CS pattern of myocardial <sup>18</sup>F-FDG uptake was almost equivalent to that of the oncology NM physician when the diagnosis by the cardiac expert NM physician was defined as a reference standard. Even though the reference standard is not made by Japanese Circulation Society guidelines, the model observer has a potential alternative for assessing the discrimination ability of <sup>18</sup>F-FDG uptake patterns of CS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Detection ability of model observer for diagnosis of active cardiac sarcoidosis on 18F-FDG-PET

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月15日

查看全文
  • Junichiro Naoi,
  • Kentaro Takanami,
  • Keisuke Kiso,
  • Miho Shidahara,
  • Hayato Odagiri,
  • Daisuke Sakai,
  • Takashi Noda,
  • Satoshi Yasuda,
  • Kei Takase

摘要

Objective

Sarcoidosis is an inflammatory granulomatous disease of unknown cause, and cardiac sarcoidosis (CS) is the main cause of death in patients with sarcoidosis. Cardiac 18F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is used to detect active CS, based on the patterns of 18F-FDG uptake in the myocardium. In this study, we investigated the ability of a model observer, Channelized Hoteling Observer (CHO), in differentiating the active CS pattern, in comparison with the diagnosis by the expert cardiac nuclear medicine (NM) physician as a reference standard.

Methods

This retrospective study included 223 patients who underwent 18F-FDG PET scans because they were clinically suspected of having CS. One expert cardiac NM physician and one oncology NM physician classified the cardiac 18F-FDG uptake into four patterns (focal, focal on diffuse, diffuse, none) for all PET images. The oncology NM physician additionally determined the confidence scale of CS expressed as a percentage (0-100). The focal and focal on diffuse patterns were defined as CS patterns. In CHO, 80 subjects (CS: 40, non-CS: 40) were used for training data sets, and 143 subjects (CS: 66, non-CS: 77) were used for evaluation data sets of objective CS discrimination ability, respectively. The confidence scale of CS by CHO was also output as a percentage (0-100). Finally, ROC analysis was used to compare discrimination ability between the oncology NM physician and CHO by refereeing the classification of the cardiac NM physician as a standard.

Results

The match rate of classified subject numbers between the two physicians was moderate (Kappa coefficient of 0.57). In comparison with the judgment of the expert cardiac NM physician, the area under the ROC curve of oncology NM medicine and that of CHO were 0.73 and 0.78, respectively.

Conclusions

The detection ability of CHO in CS pattern of myocardial 18F-FDG uptake was almost equivalent to that of the oncology NM physician when the diagnosis by the cardiac expert NM physician was defined as a reference standard. Even though the reference standard is not made by Japanese Circulation Society guidelines, the model observer has a potential alternative for assessing the discrimination ability of 18F-FDG uptake patterns of CS.